TRILLIUM THERAPEUTICS INC's ticker is and the CUSIP is 89620X506. A total of 29 filers reported holding TRILLIUM THERAPEUTICS INC in Q1 2016. The put-call ratio across all filers is - and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2021 | $6,801,000 | +23.2% | 701,201 | +36.4% | 0.07% | +7.5% |
| Q1 2021 | $5,522,000 | -34.3% | 514,175 | -10.1% | 0.07% | -40.7% |
| Q4 2020 | $8,410,000 | +4.0% | 571,675 | +0.4% | 0.11% | -26.6% |
| Q3 2020 | $8,088,000 | +25.1% | 569,154 | -28.8% | 0.15% | +77.0% |
| Q2 2020 | $6,464,000 | +840.9% | 799,000 | +370.0% | 0.09% | +102.3% |
| Q1 2020 | $687,000 | +449.6% | 170,000 | +671.1% | 0.04% | +168.8% |
| Q4 2016 | $125,000 | -57.8% | 22,047 | +10.2% | 0.02% | -68.0% |
| Q3 2016 | $296,000 | +64.4% | 20,000 | 0.0% | 0.05% | +25.0% |
| Q2 2016 | $180,000 | +80.0% | 20,000 | +84.5% | 0.04% | -2.4% |
| Q1 2016 | $100,000 | – | 10,841 | – | 0.04% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| AWM Investment Company, Inc. | 701,138 | $4,067,000 | 0.67% |
| Matrix Capital Management Company, LP | 2,288,560 | $13,274,000 | 0.33% |
| NEA Management Company, LLC | 1,250,000 | $7,250,000 | 0.31% |
| Stanley-Laman Group, Ltd. | 139,403 | $809,000 | 0.20% |
| Cormorant Asset Management, LP | 500,000 | $2,900,000 | 0.19% |
| Tekla Capital Management LLC | 468,399 | $2,717,000 | 0.10% |
| Wealth Alliance Advisory Group, LLC | 21,800 | $126,000 | 0.06% |
| PLATINUM INVESTMENT MANAGEMENT LTD | 175,339 | $1,007,000 | 0.03% |
| Artal Group S.A. | 150,000 | $870,000 | 0.02% |
| Baker Brothers Advisors | 505,262 | $2,931,000 | 0.02% |